|Articles|January 1, 2017
January 2017: Setting the Pace for the Patient Journey
Author(s)Triplefin
How Triplefin’s suite of hub-based e-solutions and customized investments in the “human touch” are outrunning the clock on prior authorization claims-a key source of delays in patient speed to therapy.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
President Trump Planning to Fire FDA Commissioner Marty Makary: Report
2
GLP-1 Patent Expiry & the Rise of Generics: Transforming the Drug Delivery Device Landscape & Procurement Strategy
3
Factors Contributing to the Growth of Radiopharmaceuticals: Q&A with Andrea Zobel and Marco Hogenboom
4
FDA Extends Priority Review of Leqembi Iqlik Subcutaneous Injection
5